PGT-M Counselling From Dwarka Sector 21: Family Reports Before IVF

A verbal history of “a genetic problem in the family” is not always enough for test development. A clinical geneticist may ask for the affected relative’s diagnostic result, parental carrier results and a family tree. If the affected person was tested years ago, clarify whether the report identifies a pathogenic variant, an uncertain finding or a broader diagnosis. Do not assume a negative screening panel excludes the specific familial condition; targeted verification may be needed before treatment decisions.

PGT-M is intended for certain known single-gene disorders. PGT-A looks at chromosome number and cannot substitute for PGT-M. PGT-SR is relevant to some chromosomal rearrangements. Each method has different indications, limitations and laboratory preparations. Ask whether the family’s diagnosis is suitable for a validated PGT-M assay, how long laboratory preparation may take and what would be reported as inconclusive. Screening and diagnosis have different meanings, and every patient deserves clear counselling about residual risk.

PGT-M usually involves producing embryos through IVF, performing a specialised laboratory biopsy and often freezing embryos while results are processed. A clinician should explain ovarian reserve, semen testing, biopsy consent, possible lack of transferable embryos and alternatives including prenatal testing. Egg retrieval, embryology, biopsy and transfer cannot be conducted at a home address. Ask who will coordinate between fertility specialist and genetics laboratory before purchasing a cycle.

Documents can sometimes be reviewed electronically and counselling arranged remotely depending on the service. That is different from promising a visiting genetics lab or a HomeIVF branch in Sector 21. Confirm the actual facility, responsible clinicians, collection options and secure handling of family genetic records. Costs may include counselling, variant confirmation, assay preparation, biopsy, embryo storage and transfer; a generic “IVF plus testing” quote may omit important stages.

HomeIVF is a doctor-led fertility and IVF care model designed to reduce unnecessary trips, not a home genetics laboratory. Medical history, family documents and some counselling may be reviewed remotely when suitably provided. Any prescribed blood collection at home depends on verified collection capability, consent and specimen handling. If IVF is appropriate, ovarian monitoring includes facility scans, with retrieval, fertilisation, embryo biopsy, freezing and transfer performed in properly equipped clinics and laboratories. A clinical geneticist and reproductive specialist should each take responsibility for their parts of the decision; neither an online tool nor a coordinator can replace informed genetic counselling.

A robust plan names the clinical geneticist, the fertility specialist and the laboratory responsible for the assay. Ask which consent forms are required and whether both partners must attend a particular appointment. The team should describe how results will be communicated, what a no-result embryo report means, and which confirmatory pregnancy testing may later be discussed. Written coordination matters because laboratory terminology can be misunderstood when it passes through several people. A coordinator can organise the sequence but must not reinterpret genetic variants independently.

Ask whether the genetic finding has been confirmed and whether the proposed test is technically feasible for the family. Request an explanation of no-result embryos, residual risk, prenatal alternatives, storage and what happens if no embryos are suitable for transfer. Clarify whether consent, payment or laboratory setup is needed before starting stimulation. Genetic counselling should use plain language and include family and reproductive values, not only laboratory success claims. A precise written plan helps avoid unnecessary procedures when the test being purchased cannot answer the family’s actual question.

Counselling, confirmation of family variants, creation or validation of an assay, IVF medicines, retrieval, embryo culture, biopsy, testing, freezing, storage and eventual transfer may be separate charges. A laboratory quote may cover only a portion of this pathway. Request fees for inconclusive findings and for a cycle that produces no embryos to test. Patients should know which charges are clinical necessities and which are optional choices. No test should be bought to solve an unrelated genetic question merely because the package lists it.

Genetic test results can affect embryo decisions and family planning, so interpretation belongs with qualified clinicians. Do not discard or transfer embryos based solely on an informal online explanation. The team should discuss uncertain and no-result findings, prenatal care and the possibility of having no embryos suitable for transfer. Any ovarian stimulation still requires ordinary medical monitoring and emergency instructions. Remote counselling does not change the need for a safe procedure facility.

Some genetic results have implications beyond the two people considering IVF. A genetic counsellor can explain whether relatives might benefit from testing and how privacy and consent should be respected. Do not circulate raw reports in family messaging groups or assume that an uncertain variant predicts disease. The correct interpretation should come from the laboratory and clinical genetics team, and the family should retain control over sensitive information.